€26.90
2.67% today
Xetra, Jul 01, 05:10 pm CET
ISIN
DE000STRA555
Symbol
SBS
Index
Sector

STRATEC Stock price

€26.20
-2.00 7.09% 1M
-3.60 12.08% 6M
-3.60 12.08% YTD
-19.65 42.86% 1Y
-61.00 69.95% 3Y
-61.20 70.02% 5Y
-23.21 46.97% 10Y
+0.40 1.55% 20Y
Xetra, Closing price Mon, Jun 30 2025
-0.60 2.24%
ISIN
DE000STRA555
Symbol
SBS
Index
Sector

Key metrics

Basic
Market capitalization
€325.8m
Enterprise Value
€411.3m
Net debt
€85.5m
Cash
€48.7m
Shares outstanding
12.2m
Valuation (TTM | estimate)
P/E
19.85 | 14.71
P/S
1.26 | 1.19
EV/Sales
1.60 | 1.50
EV/FCF
13.48
P/B
1.31
Dividends
DPS
€0.60
Yield 1Y | 5Y
2.29% | 0.96%
Growth 1Y | 5Y
9.09% | -6.51%
Payout 1Y | 3Y
45.45% | 42.57%
Increased
1 Year
Financials (TTM | estimate)
Revenue
€257.6m | €274.3m
EBITDA
€48.2m | €52.2m
EBIT
€28.7m
Net Income
€16.0m | €21.7m
Free Cash Flow
€30.5m
Growth (TTM | estimate)
Revenue
-1.64% | 6.47%
EBITDA
20.21% | 9.53%
EBIT
28.40%
Net Income
22.57% | 35.21%
Free Cash Flow
1,426.00%
Margin (TTM | estimate)
Gross
29.65%
EBITDA
18.70% | 19.02%
EBIT
11.16%
Net
6.22% | 7.90%
Free Cash Flow
11.85%
Financial Health
Equity Ratio
54.49%
Return on Equity
6.61%
ROCE
8.10%
ROIC
5.95%
Debt/Equity
0.55
More
EPS
€1.32
FCF per Share
€2.51
Short interest
-
Employees
1.46k
Rev per Employee
€180.00k
Show more

Is STRATEC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,951 stocks worldwide.

STRATEC Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a STRATEC forecast:

7x Buy
54%
6x Hold
46%

Analyst Opinions

13 Analysts have issued a STRATEC forecast:

Buy
54%
Hold
46%

Financial data from STRATEC

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
258 258
2% 2%
100%
- Direct Costs 181 181
8% 8%
70%
76 76
18% 18%
30%
- Selling and Administrative Expenses 37 37
17% 17%
14%
- Research and Development Expense 12 12
33% 33%
5%
48 48
20% 20%
19%
- Depreciation and Amortization 19 19
10% 10%
8%
EBIT (Operating Income) EBIT 29 29
28% 28%
11%
Net Profit 16 16
23% 23%
6%

In millions EUR.

Don't miss a Thing! We will send you all news about STRATEC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STRATEC Stock News

AD HOC NEWS
about one month ago
STRATEC SE / DE000STRA555
More STRATEC News

Company Profile

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Head office Germany
CEO Marcus Wolfinger
Employees 1,462
Founded 1979
Website www.stratec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today